Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut H-J Schmidt

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|January 3, 2009
Role of genotyping in Wilson's diseaseHartmut H-J Schmidt
Circulation|January 16, 2002
Consider cardiomyopathy in subjects with familial partial lipodystrophyHartmut H-J Schmidt
Molecular Genetics and Metabolism|July 6, 2005
Commentary on Vrabelova et alHartmut H-J Schmidt
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|May 11, 2010
[Organ transplantation in Germany - Legal framework and organizational management]Wolf Rommel, Hartmut H J Schmidt
Deutsches Arzteblatt International|March 18, 2017
In ReplyHartmut H-J Schmidt, Thomas Gutmann
Advances in Therapy|February 18, 2020
Silymarin as Supportive Treatment in Liver Diseases: A Narrative ReviewAnton Gillessen, Hartmut H-J Schmidt
Hepatology (Baltimore, Md.)|June 26, 2020
Immune-Mediated Hepatitis Induced by Therapy With Alemtuzumab in a Patient With Multiple SclerosisFabian J Bolte, Hartmut H-J Schmidt, Bernhard Schlevogt
Deutsche Medizinische Wochenschrift (1946)|March 11, 2017
[Extracorporeal Liver Replacement Therapy: Already Standard Procedure]Hans U Gerth, Michele Pohlen, Hartmut H J Schmidt
European Journal of Internal Medicine|February 25, 2009
Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitisPia Lebiedz, Christian August, Wolfram Domschke, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2019
APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNAChristoph Niemietz, Oksana Nadzemova, Andree Zibert, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|January 3, 2009
Role of genotyping in Wilson's diseaseHartmut H-J Schmidt
Circulation|January 16, 2002
Consider cardiomyopathy in subjects with familial partial lipodystrophyHartmut H-J Schmidt
Molecular Genetics and Metabolism|July 6, 2005
Commentary on Vrabelova et alHartmut H-J Schmidt
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|May 11, 2010
[Organ transplantation in Germany - Legal framework and organizational management]Wolf Rommel, Hartmut H J Schmidt
Deutsches Arzteblatt International|March 18, 2017
In ReplyHartmut H-J Schmidt, Thomas Gutmann
Advances in Therapy|February 18, 2020
Silymarin as Supportive Treatment in Liver Diseases: A Narrative ReviewAnton Gillessen, Hartmut H-J Schmidt
Hepatology (Baltimore, Md.)|June 26, 2020
Immune-Mediated Hepatitis Induced by Therapy With Alemtuzumab in a Patient With Multiple SclerosisFabian J Bolte, Hartmut H-J Schmidt, Bernhard Schlevogt
Deutsche Medizinische Wochenschrift (1946)|March 11, 2017
[Extracorporeal Liver Replacement Therapy: Already Standard Procedure]Hans U Gerth, Michele Pohlen, Hartmut H J Schmidt
European Journal of Internal Medicine|February 25, 2009
Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitisPia Lebiedz, Christian August, Wolfram Domschke, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2019
APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNAChristoph Niemietz, Oksana Nadzemova, Andree Zibert, et al.
Pageof 8